Telangana govt signs several new MoUs at BioAsia 2025

Hyderabad: The Telangana government welcomed a wave of global investments on the first day of BioAsia 2025, reinforcing Hyderabad’s position as a life sciences powerhouse

Green Pharma City Expansion:17 pharma companies, including Granules, Biological E, Bharat Biotech, and Sai Life Sciences, signed MoUs, bringing investments worth Rs11,100 crore and creating 22,300 new jobs.

MSD:US-based pharmaceutical giant joins Telangana’s vibrant ecosystem, leveraging the city's advanced technology and life sciences capabilities to accelerate growth.

Agilisium (Los Angeles, USA): Launched a new office at RMZ Spire, Hyderabad, along with a Life Sciences and Innovation & Talent Development Lab.

ALS: A global leader in testing and certification services, establishing a state-of-the-art biopharma cGMP testing lab in Genome Valley.

Meishi Pharma - A Lotus Company:Setting up its 2nd R&D centre in Hyderabad under its new Indian subsidiary, Meishi Pharma Services Pvt Ltd

Collaborations to propel innovation:

University of Queensland & Telangana Life Sciences:A Letter of Intent signed to collaborate on advanced research, digital healthcare, and AI-driven innovations.

Indian Digital Health Activator (WEF Initiative):Telangana to host India’s first hub under the framework to bridge healthcare supply-demand gaps and build a robust digital health ecosystem.

Innovative Pharmaceutical Services Organization (IPSO):11 leading Contract Research, Development, and Manufacturing Organization (CRDMO) firms join forces to shape the future of contract research and development, nurture talent, and enhance global competitiveness.

I Health Innovation Manchester & T-Hub: A partnership to drive innovation in healthcare, MedTech, diagnostics, and digital health solutions, boosting patient outcomes with cutting-edge advancements.